First Personal Financial Services Ironwood Pharmaceuticals Inc Transaction History

First Personal Financial Services

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2018 Aug 07, 2018	SELL	$11.83 - $16.2 $10,031 - $13,737	-848 Closed	0 $0
Q1 2018 May 10, 2018	SELL	$11.13 - $13.63 $6,344 - $7,769	-570 Reduced 40.2%	848 $13,000
Q4 2017 Jan 25, 2018	SELL	$12.16 - $14.58 $13,813 - $16,562	-1,136 Reduced 44.48%	1,418 $21,000
Q3 2017 Nov 01, 2017	BUY	$12.07 - $14.87 $30,826 - $37,977	2,554	2,554 $40,000

246

171M

11.2M

28.5K

Ticker IRWD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 153,231,008
Market Cap $659M
Description
Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...

Get notified when there are updates to the investment portfolio of First Personal Financial Services, based on Form 13F filings with the SEC.

Stay updated on First Personal Financial Services with notifications on news.